Catalogue Number
AV-H17069
Analysis Method
HPLC,NMR,MS
Specification
98%
Storage
2-8°C
Molecular Weight
368.27
Appearance
Botanical Source
Lycoris radiata (L’Her.) Herb.
Structure Type
Other Alkaloids
Category
Standards;Natural Pytochemical;API
SMILES
CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br
Synonyms
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-olhydrobromid/NIVALIN,HBR/(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide/(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol bromhydrate/Galanthamine hydrobromide (1:1)/GALANTHAMIDE HYDROBROMIDE/[3H]-Galantamine hydrobromide/galanthamine bromhydrate (1:1)/Galantamine hydrobromide (JAN/USAN)/Galanthamine HBr/Galanthamine (hydrobromide)/Galantamine hydrobromide/(-)-Galanthaminium bromide/NIVALIN/6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-, hydrobromide (1:1)/galanthaminhydrobromid(1:1)/GALANTHAMINE HYDROBROMIDUM/GALANTAMINE HBR/6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-, hydrobromide
IUPAC Name
(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide
Density
Solubility
Flash Point
Boiling Point
Melting Point
256 °C
InChl
InChl Key
WGK Germany
RID/ADR
HS Code Reference
Personal Projective Equipment
Correct Usage
For Reference Standard and R&D, Not for Human Use Directly.
Meta Tag
provides coniferyl ferulate(CAS#:1953-04-4) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
No Technical Documents Available For This Product.
31976781
Alzheimer’s disease treatment; adverse effects; cholinesterase inhibitors; donepezil; galantamine; rivastigmine; safety of cholinesterase inhibitors; side effects; symptomatic treatment for Alzheimer’s disease
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease.
Haake A1, Nguyen K1, Friedman L2, Chakkamparambil B1, Grossberg GT1.
2020 Feb
31663530
A fluorescent probe for butyrylcholinesterase activity in human serum based on a fluorophore with specific binding affinity for human serum albumin.
Yoo S1, Han MS1.
2019 Dec 18
31526637
Acetylcholinesterase inhibitor; Alkaloid; Bioanalytical device; Immobilized enzyme reactor; MS
Online acetylcholinesterase inhibition evaluation by high-performance liquid chromatography-mass spectrometry hyphenated with an immobilized enzyme reactor.
Yuan Y1, Zhao M1, Riffault-Valois L1, Ennahar S1, Bergaentzle M1, Marchioni E2.
2020 Jan 4